MedPath

Nantes University Hospital

Nantes University Hospital logo
🇫🇷France
Ownership
Private
Established
1503-01-01
Employees
10K
Market Cap
-
Website
https://www.chu-nantes.fr

18F-deoxyglucose (FDG) PET-CMD

Not Applicable
Completed
Conditions
Patients With Idiopathic Dilated Cardiomyopathy
Interventions
Drug: 18F-deoxyglucose (FDG)
First Posted Date
2014-03-05
Last Posted Date
2022-07-26
Lead Sponsor
Nantes University Hospital
Target Recruit Count
30
Registration Number
NCT02078141
Locations
🇫🇷

Nantes UH, Nantes, France

🇫🇷

West Cancerology Institute/Nantes UH : PET plateform, Saint Herblain, France

Dolutegravir + Rilpivirine Switch Study (DORISS)

Phase 2
Withdrawn
Conditions
HIV Infection
HAART-treated
Virologically Controlled
Interventions
Drug: Arm 1 (intervention)
Drug: Arm 2 (control)
First Posted Date
2014-02-24
Last Posted Date
2015-08-28
Lead Sponsor
Nantes University Hospital
Registration Number
NCT02069834
Locations
🇫🇷

CHU Guadeloupe, Point-a-pitre, Guadeloupe, France

🇫🇷

Chu Jean Minjoz, Besançon, France

🇫🇷

Hôpital Avicenne, Bobigny, France

and more 22 locations

Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)

Phase 2
Completed
Conditions
HIV-1 Infection
Interventions
Drug: Abacavir/Lamivudine/Dolutegravir
First Posted Date
2014-02-20
Last Posted Date
2016-02-22
Lead Sponsor
Nantes University Hospital
Target Recruit Count
53
Registration Number
NCT02067767
Locations
🇫🇷

La Roche-sur-Yon Hospital, La Roche-sur-Yon, France

🇫🇷

Nantes University Hospital, Nantes, France

Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.

Not Applicable
Terminated
Conditions
Multiple Myeloma in Older Patients
Interventions
Other: Vulnerability and therapeutic changes in older patients with multiple myeloma.
First Posted Date
2014-02-14
Last Posted Date
2023-05-23
Lead Sponsor
Nantes University Hospital
Target Recruit Count
48
Registration Number
NCT02063113
Locations
🇫🇷

CHD Vendée La Roche sur Yon, La Roche-sur-Yon, France

🇫🇷

CHU de Nantes, Nantes, France

ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF

Phase 4
Terminated
Conditions
Kidney Transplantation
Interventions
Drug: Anti-Thymocyte Globulins treatment
First Posted Date
2014-02-06
Last Posted Date
2017-11-21
Lead Sponsor
Nantes University Hospital
Target Recruit Count
19
Registration Number
NCT02056938
Locations
🇫🇷

Nantes Universitary hospital, Nantes, France

🇫🇷

Universitary hospital of Lyon, Lyon, France

🇫🇷

Necker Hospital, Paris, France

and more 1 locations

Reduce Pediatric Sedation to Reduce Mechanical Ventilation Complication in ICU

Completed
Conditions
Mechanical Ventilation Complication
First Posted Date
2014-01-20
Last Posted Date
2021-09-16
Lead Sponsor
Nantes University Hospital
Target Recruit Count
106
Registration Number
NCT02040168
Locations
🇫🇷

Nantes University Hospital, Nantes, Loire-Atlantique, France

Transversal, Controlled and Not Randomized Study, Laying on the Desire of Children and Eating Disorders in a Population of Infertile Women

Not Applicable
Terminated
Conditions
Eating Disorders
Infertility
Interventions
Other: Autoquestionnary
Other: semi-structured interview
First Posted Date
2014-01-07
Last Posted Date
2015-03-10
Lead Sponsor
Nantes University Hospital
Target Recruit Count
71
Registration Number
NCT02029365
Locations
🇫🇷

Nantes university Hospital, Nantes, France

National Study on the Quality of Life of Patients With Anorectal Malformation

Completed
Conditions
Anorectal Malformation
Interventions
Other: Quality of life questionnaire
First Posted Date
2014-01-07
Last Posted Date
2017-07-19
Lead Sponsor
Nantes University Hospital
Target Recruit Count
762
Registration Number
NCT02029248
Locations
🇫🇷

CHU Rennes, Rennes, France

🇫🇷

CH Saint Brieuc, Saint Brieuc, France

🇫🇷

CHU Reims, Reims, France

and more 34 locations

TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves

Not Applicable
Completed
Conditions
Patients Receiving Animal-derived Bioprosthetic Heart Valves
Interventions
Device: Patients receiving animal-derived bioprosthetic heart valves.
Other: Echocardiography (3)
Other: Echocardiography (1)
Other: Echocardiography (2)
Biological: Blood sample (3)
Biological: Blood sample (1)
Biological: Blood sample (2)
First Posted Date
2013-12-30
Last Posted Date
2020-11-02
Lead Sponsor
Nantes University Hospital
Target Recruit Count
1668
Registration Number
NCT02023970
Locations
🇨🇦

University of Manitoba, Winnipeg, Manitoba, Canada

🇫🇷

Nantes University Hospital, Nantes, France

🇮🇹

University of Padova Medical School, Italy, Padova, Italy

and more 2 locations

Ultrasonography Assessment of Septic Arthritis on Native Joint

Not Applicable
Completed
Conditions
Septic Arthritis
Interventions
Other: Ultrasonography assessment
First Posted Date
2013-12-23
Last Posted Date
2016-03-25
Lead Sponsor
Nantes University Hospital
Target Recruit Count
28
Registration Number
NCT02018952
Locations
🇫🇷

CH de Nantes, Nantes, France

🇫🇷

CH Saint-Nazaire, Saint-Nazaire, France

🇫🇷

CH La Roche-sur-Yon, La Roche-sur-Yon, France

© Copyright 2025. All Rights Reserved by MedPath